Each year, thousands of incarcerated individuals leave their facilities with little to no educational or occupational experiences; many suffer from different mental disorders and have other health-related problems. These issues lead to failed societal reintegration, increases in recidivism, readmittance back into prison, and $600 billion being spent directly on re-incarceration annually. Studies have shown the benefits of rehabilitative measures in reducing recidivism rates in the highest-risk and highest-need inmates better than solely focusing on lower-risk inmates; however, the examination of current state rehabilitation programs has fallen short. Due to these reasons, this review examined the efficacy of current state rehabilitation and reintegration programs in lowering recidivism rates in high-risk incarcerated individuals. One reviewer searched PubMed and Scopus databases on February 22nd, 2021, and March 19th, 2021, respectively, for peer-reviewed articles that reported studies on high-risk incarcerated adults based in the United States and published between 2010-2021. Of the 303 articles reviewed, 6 met the inclusion criteria and were included in this rapid review. Reviewing recidivism rates and cost analyses from six different states, the ensuing results suggested that the model used by the Swift and Sure, Sanctions Probation Program offered by Michigan was the most efficient rehabilitation program based on total cost and recidivism rates. Specifically, this can be attributed to the program’s interventions implemented at individual and programmatic levels. Using this information, public health officials can suggest recommendations to other states to modify their reintegration programs to cut costs and increase their ability to lower recidivism rates.
Recommended CitationErianne, Robert, "The Efficacy of Rehabilitation and Reintegration Programs at Lowering Recidivism in High-Risk Incarcerated Populations: A Rapid Review of the Literature" (2021). Master of Public Health Capstone Presentations. Presentation 400.